CareDx Net Profit Margin 2013-2025 | CDNA
CareDx net profit margin from 2013 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| CareDx Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.35B | $0.06B | 18.16% |
| 2024-12-31 | $0.33B | $0.05B | 15.87% |
| 2024-09-30 | $0.31B | $-0.15B | -46.65% |
| 2024-06-30 | $0.30B | $-0.16B | -54.55% |
| 2024-03-31 | $0.28B | $-0.19B | -67.64% |
| 2023-12-31 | $0.28B | $-0.19B | -67.86% |
| 2023-09-30 | $0.30B | $-0.09B | -30.41% |
| 2023-06-30 | $0.31B | $-0.08B | -27.27% |
| 2023-03-31 | $0.32B | $-0.08B | -25.39% |
| 2022-12-31 | $0.32B | $-0.08B | -23.99% |
| 2022-09-30 | $0.32B | $-0.08B | -23.58% |
| 2022-06-30 | $0.32B | $-0.07B | -22.22% |
| 2022-03-31 | $0.31B | $-0.05B | -16.23% |
| 2021-12-31 | $0.30B | $-0.03B | -10.47% |
| 2021-09-30 | $0.28B | $-0.02B | -6.88% |
| 2021-06-30 | $0.25B | $-0.01B | -3.95% |
| 2021-03-31 | $0.22B | $-0.02B | -6.79% |
| 2020-12-31 | $0.19B | $-0.02B | -10.42% |
| 2020-09-30 | $0.17B | $-0.02B | -12.43% |
| 2020-06-30 | $0.15B | $-0.02B | -13.33% |
| 2020-03-31 | $0.14B | $-0.02B | -15.11% |
| 2019-12-31 | $0.13B | $-0.02B | -18.11% |
| 2019-09-30 | $0.12B | $-0.02B | -19.13% |
| 2019-06-30 | $0.10B | $-0.04B | -39.22% |
| 2019-03-31 | $0.09B | $-0.05B | -51.69% |
| 2018-12-31 | $0.08B | $-0.05B | -61.04% |
| 2018-09-30 | $0.07B | $-0.08B | -113.64% |
| 2018-06-30 | $0.06B | $-0.07B | -121.05% |
| 2018-03-31 | $0.05B | $-0.06B | -115.69% |
| 2017-12-31 | $0.05B | $-0.06B | -114.29% |
| 2017-09-30 | $0.05B | $-0.04B | -82.98% |
| 2017-06-30 | $0.05B | $-0.03B | -61.70% |
| 2017-03-31 | $0.05B | $-0.04B | -76.09% |
| 2016-12-31 | $0.04B | $-0.04B | -95.12% |
| 2016-09-30 | $0.04B | $-0.03B | -78.38% |
| 2016-06-30 | $0.03B | $-0.03B | -87.50% |
| 2016-03-31 | $0.03B | $-0.02B | -75.00% |
| 2015-12-31 | $0.03B | $-0.01B | -46.43% |
| 2015-09-30 | $0.03B | $-0.01B | -27.59% |
| 2015-06-30 | $0.03B | $0.00B | -13.79% |
| 2015-03-31 | $0.03B | 0 | 0.00% |
| 2014-12-31 | $0.03B | $0.00B | 3.57% |
| 2014-09-30 | $0.03B | 0 | 0.00% |
| 2014-06-30 | $0.03B | $0.00B | -8.00% |
| 2014-03-31 | $0.02B | $0.00B | -17.39% |
| 2013-12-31 | $0.02B | $0.00B | -18.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.064B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.850B | 26.98 |
| Elevance Health (ELV) | United States | $84.468B | 10.90 |
| CVS Health (CVS) | United States | $83.959B | 10.44 |
| Cencora (COR) | United States | $56.658B | 19.71 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.415B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.653B | 17.56 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.432B | 0.00 |
| Solventum (SOLV) | United States | $12.967B | 13.73 |
| CochLear (CHEOY) | Australia | $12.826B | 0.00 |
| ICON (ICLR) | Ireland | $11.783B | 10.95 |
| Revvity (RVTY) | United States | $11.516B | 19.82 |
| Viatris (VTRS) | United States | $10.434B | 3.58 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| HealthEquity (HQY) | United States | $8.991B | 39.38 |
| Medpace Holdings (MEDP) | United States | $8.943B | 23.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.378B | 14.46 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.305B | 25.35 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 36.47 |
| Sotera Health (SHC) | United States | $3.162B | 17.97 |
| Surgery Partners (SGRY) | United States | $2.782B | 36.18 |
| Alignment Healthcare (ALHC) | United States | $2.710B | 0.00 |
| Concentras Parent (CON) | United States | $2.631B | 15.21 |
| Organon (OGN) | United States | $2.600B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.537B | 97.72 |
| PACS (PACS) | United States | $1.951B | 0.00 |
| Ardent Health (ARDT) | United States | $1.877B | 8.00 |
| Premier (PINC) | United States | $1.799B | 13.66 |
| Progyny (PGNY) | United States | $1.792B | 39.45 |
| GoodRx Holdings (GDRX) | United States | $1.754B | 35.07 |
| Teladoc Health (TDOC) | United States | $1.328B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| Establishment Labs Holdings (ESTA) | $1.084B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.670B | 10.14 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| Embecta (EMBC) | United States | $0.580B | 3.91 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.476B | 39.17 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.301B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.258B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| Oncology Institute (TOI) | United States | $0.192B | 0.00 |
| So-Young (SY) | China | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.113B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.095B | 0.00 |
| KindlyMD (NAKA) | United States | $0.085B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |